Analysis of Prescription Drug Utilization with Beta Regression Models

@article{Gan2020AnalysisOP,
  title={Analysis of Prescription Drug Utilization with Beta Regression Models},
  author={Guojun Gan and Emiliano A. Valdez},
  journal={arXiv: Applications},
  year={2020}
}
The healthcare sector in the U.S. is complex and is also a large sector that generates about 20% of the country's gross domestic product. Healthcare analytics has been used by researchers and practitioners to better understand the industry. In this paper, we examine and demonstrate the use of Beta regression models to study the utilization of brand name drugs in the U.S. to understand the variability of brand name drug utilization across different areas. The models are fitted to public datasets… 

References

SHOWING 1-10 OF 42 REFERENCES
Managed Care and Health Care Utilization: Specification of Bivariate Models Using Copulas
TLDR
It is found that managed care is in general associated with higher care utilization and evidence is also found on the underlying incentives of both patients and medical providers.
Predicting the Frequency and Amount of Health Care Expenditures
Abstract This article extends the standard two-part model for predicting health care expenditures to the case where multiple events may occur within a one-year period. The first part of the extended
Testing Alternative Regression Frameworks for Predictive Modeling of Health Care Costs
TLDR
This analysis was performed based on a dataset of 30,000 insureds containing claims information from two contiguous years and shows that the traditional regression approach does not perform well and that more accurate models are possible.
Bayesian nonparametric regression models for modeling and predicting healthcare claims
Accuracy of Long-Range Actuarial Projections of Health Care Costs
The Office of the Actuary, mandated to provide projections of future medical spending for use by the U.S. Medicare and Medicaid programs, publishes forecasts that have been widely used by private
A Comparative Analysis Of Chronic And Nonchronic Insured Commercial Member Cost Trends
Abstract Disease management (DM) is increasingly encountered in health plans and employer groups as a health care intervention targeted to individuals with chronic diseases (“Chronics”). To justify
MODEL SELECTION AND AVERAGING OF HEALTH COSTS IN EPISODE TREATMENT GROUPS
TLDR
It is found that Random Forest feature selection is computationally efficient and sufficiently accurate, hence being preferred in this large data set of ETGs, and Bayesian model averaging is preferred because of the posterior model probabilities.
Exploring the use of machine learning for risk adjustment: A comparison of standard and penalized linear regression models in predicting health care costs in older adults
TLDR
Health care insurers, providers and policy makers may benefit from adopting penalized regression such as lasso regression for cost prediction to improve risk adjustment and population health management and thus better address the underlying needs and risk of the populations they serve.
Potential “Savings” of Medicare: The Analysis of Medicare Advantage and Accountable Care Organizations
TLDR
The results show that Medicare Advantage plans are more efficient in reducing health expenditures but incur higher administrative costs, and compared to the profit efficiency of Medicaid managed care plans, Medicare Advantage should have the potential for more Medicare market penetration from the supply (insurer) side.
Spatial statistical modelling of insurance risk: a spatial epidemiological approach to car insurance
ABSTRACT Spatial models, such as the Besag, York and Mollie (BYM) model, have long been used in epidemiology and disease mapping. A common research question in these subjects is modelling the number
...
1
2
3
4
5
...